Komori
SHO-BOND Holdings (1414) · InitiativeAdvanced

Continuation of Research and Development Activities

First written in FY2017-Q1. 20 of 30 entries say "Restated". Latest entry: FY2026.

30entries
11years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2018-Q1 – FY2020-Q3AdvancedFY2024 – FY20262016: 12017: 420172018: 320182019: 220192020: 420202021: 420212022: 320222023: 320232024: 320242025: 120252026: 22026
Same theme, other companies
Promotion of R&D in Systems and Other Technologies for Construction and Vehicle ManagementA theme 24 companies write about · 0 as a headwind · 26 as a tailwind

18 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 24 companies compared. The sentences above are computed from all 24.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「The company invested ¥641 million in R&D during the fiscal year. This environmentally considerate concrete uses expanded waste-glass aggregate as coarse aggregate, making it easier to demolish. It newly developed a simplified version of AI Diagnostician that can perform assessments using only images taken with a smartphone camera. It has also begun operating an assistant AI to reduce the burden on site managers.」

    R&D expenses were ¥641 million. The company developed environmentally considerate ultra-rapid-hardening concrete using expanded waste-glass aggregate, mechanical joints for precast PC deck slabs and a smartphone-compatible simplified version of AI Diagnostician. The assistant AI has entered operation.
  2. 2026-08-10AdvancedEarnings

    「Research and development expenses ¥565 million ¥641 million」

    Research and development expenses increased from ¥565 million in the previous fiscal year to ¥641 million.
  3. FY2025AdvancedAnnual report

    「The company invested ¥565 million in R&D during the fiscal year. To address concrete deterioration, it developed a concrete protection coating method using an environmentally considerate water-based paint. It developed and rolled out an iPad version of AI Diagnostician, which uses AI to assess deterioration in concrete structures and propose repairs. It also newly developed a simplified version of AI Diagnostician that can perform assessments using only images taken with a smartphone camera.」

    The company invested ¥565 million in R&D and advanced development of a water-based protective coating method, transparent resin, ultra-rapid-hardening concrete and a smartphone-compatible simplified version of AI Diagnostician.
  4. FY2024AdvancedAnnual report

    「The company invested ¥626 million in R&D during the fiscal year. It developed and commercialized a gel product containing lithium nitrite after verifying its effectiveness at the company's research institute and in the field. Internal implementation of AI Diagnostician, which assesses deterioration in concrete structures and proposes repairs using AI, has been completed. The company has begun developing an assistant AI to reduce the burden on site managers.」

    The company invested ¥626 million in R&D, commercialized a gel product containing lithium nitrite, completed internal implementation of AI Diagnostician and began developing an assistant AI.
  5. FY2024-Q3RestatedAnnual report

    「Total R&D expenses for the cumulative third quarter were ¥464 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter.」

    R&D expenses were ¥464 million, but the company stated that there were no material changes in the status of its R&D activities.
  6. FY2024-Q2RestatedAnnual report

    「Total R&D expenses for the cumulative second quarter were ¥312 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter.」

    The company recorded R&D expenses of ¥312 million but stated that there were no material changes in the status of its R&D activities.
  7. FY2024-Q1RestatedAnnual report

    「Total R&D expenses for the cumulative first quarter were ¥140 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter.」

    The company recorded R&D expenses of ¥140 million but stated that there were no material changes in the status of its R&D activities.
  8. FY2023AdvancedAnnual report

    「The company invested ¥690 million in R&D during the fiscal year. It completed development of a water-based concrete surface-coating method that requires fewer construction steps, can be completed in less time and is easy to handle. Internal implementation of AI Diagnostician, which was trained through deep learning on the company's extensive repair-case data, has also been completed.」

    The company invested ¥690 million in R&D and completed development of a water-based concrete surface-coating method, dedicated adhesives and special replacement concrete. Internal implementation of AI Diagnostician was completed, and development of systems using augmented reality and image-recognition AI is also under way.
  9. FY2023-Q2RestatedAnnual report

    「Total R&D expenses for the cumulative second quarter were ¥335 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter.」

    The company recorded R&D expenses of ¥335 million but stated that there were no material changes in the status of its R&D activities.
  10. FY2023-Q1RestatedAnnual report

    「Total R&D expenses for the cumulative first quarter were ¥133 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter.」

    The company recorded R&D expenses of ¥133 million and stated that there were no material changes in the status of its R&D activities.
  11. FY2022AdvancedAnnual report

    「The company invested ¥668 million in R&D during the fiscal year. In the past, identifying the causes of deterioration in concrete structures and designing repairs required detailed surveys and material analysis of collected samples. The company developed an AI system for deterioration assessment and repair-method selection as a productivity tool for this process.」

    The company invested ¥668 million in R&D and developed an AI system for deterioration assessment and repair-method selection. Development of resin- and cement-based repair materials and methods to extend service life is also continuing.
  12. FY2022-Q3RestatedAnnual report

    「Total R&D expenses for the cumulative third quarter were ¥476 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter.」

    The company recorded R&D expenses of ¥476 million but stated that there were no material changes in the status of its R&D activities.
  13. FY2022-Q1RestatedAnnual report

    「Total R&D expenses for the cumulative first quarter were ¥168 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter.」

    The company recorded R&D expenses of ¥168 million and stated that there were no material changes in the status of its R&D activities.
  14. FY2021AdvancedAnnual report

    「The company invested ¥675 million in R&D during the fiscal year. It has begun developing a system that uses AI image diagnostics to identify the causes of structural deterioration and propose repair methods, with the aim of improving repair-design productivity, as well as a safety-management support system that uses AI voice diagnostics to improve health and safety standards at construction sites.」

    The company invested ¥675 million in R&D and began developing an AI image diagnostic system to support repair design and an AI voice diagnostic system to support safety management.
  15. FY2021-Q3RestatedAnnual report

    「Total R&D expenses for the cumulative third quarter were ¥450 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter.」

    The company recorded R&D expenses of ¥450 million but stated that there were no material changes in the status of its R&D activities.
  16. FY2021-Q2RestatedAnnual report

    「Total R&D expenses for the cumulative second quarter were ¥310 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter.」

    The company recorded R&D expenses of ¥310 million but stated that there were no material changes in the status of its R&D activities.
  17. FY2021-Q1RestatedAnnual report

    「Total R&D expenses for the cumulative first quarter were ¥140 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter.」

    The company recorded R&D expenses of ¥140 million but stated that there were no material changes in the status of its R&D activities.
  18. FY2020AdvancedAnnual report

    「The company invested ¥676 million in R&D during the fiscal year. It is currently conducting joint research with relevant organizations and construction companies on proprietary repair methods tailored to the specific needs of each organization, and has confirmed their effectiveness through trial construction at actual facilities. To further improve productivity, the company has begun developing an AI slab deterioration assessment system that uses image processing to determine the service life of road bridge deck slabs.」

    R&D expenses were ¥676 million. In addition to joint research and trial construction, the company has begun developing an AI system to assess deck slab deterioration. Development of resin- and cement-based repair materials, rapid construction methods and 3D modeling has also been fleshed out.
  19. FY2020-Q3RestatedAnnual report

    「Total R&D expenses for the cumulative third quarter were ¥411 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter.」

    The company recorded R&D expenses of ¥411 million but stated that there were no material changes in the status of its R&D activities.
  20. FY2020-Q2RestatedAnnual report

    「Total R&D expenses for the cumulative second quarter were ¥276 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter.」

    The company recorded R&D expenses of ¥276 million but stated that there were no material changes in the status of its R&D activities.
  21. FY2019-Q3RestatedAnnual report

    「Total R&D expenses for the cumulative third quarter were ¥470 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter.」

    R&D expenses were ¥470 million, but the company stated that there were no material changes in the status of its R&D activities.
  22. FY2019-Q2RestatedAnnual report

    「Total R&D expenses for the cumulative second quarter were ¥339 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter.」

    The company recorded R&D expenses of ¥339 million but stated that there were no material changes in the status of its R&D activities.
  23. FY2019-Q1RestatedAnnual report

    「Total R&D expenses for the cumulative first quarter were ¥164 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter.」

    The company recorded R&D expenses of ¥164 million but stated that there were no material changes in the status of its R&D activities.
  24. FY2018-Q3RestatedAnnual report

    「Total R&D expenses for the cumulative third quarter were ¥274 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter.」

    R&D expenses were ¥274 million, but the company stated that there were no material changes in the status of its R&D activities.
  25. FY2018-Q2RestatedAnnual report

    「Total R&D expenses for the cumulative second quarter were ¥187 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter.」

    The company recorded R&D expenses of ¥187 million but stated that there were no material changes in the status of its R&D activities.
  26. FY2018-Q1RestatedAnnual report

    「Total R&D expenses for the cumulative first quarter were ¥93 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter.」

    The company recorded R&D expenses of ¥93 million and stated that there were no material changes in the status of its R&D activities.
  27. FY2017AdvancedAnnual report

    「The Group invested ¥364 million in research and development during the current consolidated fiscal year. The Group's research and development activities primarily relate to domestic construction and are not presented by segment. The Group is currently conducting joint research into proprietary repair methods tailored to the specific needs of individual institutions, and is verifying their effectiveness through trial construction at actual facilities. The Company's Repair Engineering Research Institute has long had a rubber-tire wheel-load testing machine capable of reproducing fatigue deterioration in road bridge deck slabs caused by wheel loads. The Company is currently planning to install a steel-wheel wheel-load testing machine that will enable more pronounced testing, as well as the latest composite-cycle testing machine capable of accelerating and reproducing coating deterioration on steel bridges.」

    R&D expenses were ¥364 million. The effectiveness of the joint research was confirmed through trial construction, and plans to install a steel-wheel wheel-load running test machine and other equipment are being developed in detail.
  28. FY2017-Q3RestatedAnnual report

    「Total research and development expenses during the first nine months of the current consolidated fiscal year were ¥256 million. There were no material changes in the status of the Group's research and development activities during the first nine months of the current consolidated fiscal year.」

    Research and development expenses were reported at ¥256 million, with no material changes in the status of research and development activities.
  29. FY2017-Q2RestatedAnnual report

    「Total research and development expenses during the first six months of the current consolidated fiscal year were ¥168 million. There were no material changes in the status of the Group's research and development activities during the first six months of the current consolidated fiscal year.」

    Research and development expenses were reported at ¥168 million, with no material changes in the status of research and development activities.
  30. FY2017-Q1First statedAnnual report

    「Total research and development expenses during the first six months of the current consolidated fiscal year were ¥78 million. There were no material changes in the status of the Group's research and development activities during the first six months of the current consolidated fiscal year.」

    Research and development expenses were ¥78 million for the quarter, with no material changes in research and development activities.
Moved together

"Rigorous Cost Management and Higher Productivity" moved the same way as this thread, in the same document, in 9 of its 30 moves.

997665★123456
  1. ★This thread
  2. 1Rigorous Cost Management and Higher Productivity9×
  3. 2Dividends Funded by Retained Earnings9×
  4. 3Quarterly Revenue and Profit Growth7×
  5. 4Assessing the Rationale for Strategic Shareholdings Based on Business Relationships and Reducing Holdings6×
  6. 5¥10 billion in share repurchases over three years and a total payout ratio of at least 75%6×
  7. 6Repair Costs and Risk of Additional Losses Associated with Welding Defects in Bridge Fall Prevention Devices5×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for SHO-BOND Holdings yet. It last moved in the Earnings of 2026-08-10: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Continuation of Research and Development Activities | SHO-BOND Holdings Co.,Ltd. (1414) | Komori